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Residential treatment is a necessary element of treatment in some cases of anorexia 
nervosa, where it is used prior to transitioning to complete the treatment in a less intensive 
setting. This study tests how effective residential treatment is at helping adolescent and adult 
patients to reduce their eating pathology to levels that can be managed in outpatient settings. 
Ninety-eight patients with anorexia nervosa started treatment in a routine residential setting 
(83 completers). The adolescent and adult groups showed comparable levels of benefit, 
showing gains in weight and reductions in eating pathology, compatible with transitioning to 
less intensive treatment. Change was particularly substantial over the first six weeks. This 
effectiveness study has shown that an appropriate period of residential treatment can be used 
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Effectiveness of treatment for adolescents and adults with anorexia nervosa in a 
routine residential setting 
 
Treatments for anorexia nervosa are generally less effective than comparable 
treatments for non-underweight weight eating-disordered patients (e.g., Watson & Bulik, 
2013). While several outpatient therapies for anorexia nervosa have been developed and 
trialled in recent years (e.g., Byrne et al., 2017; Fairburn et al., 2013; Schmidt et al., 2015; 
Zipfel et al., 2014), their recovery rates remain low, particularly when considering the key 
outcome variable of weight gain (Bulik et al., 2007). Furthermore, there are no medications 
that appear to be effective for anorexia nervosa at present. Combined with the level of physical 
risk associated with low weight and related behaviours, it is unsurprising that there is a greater 
use of hospitalisation for such patients than for non-underweight eating-disordered patients. 
That level of hospitalisation varies substantially across cultures, as a result of different 
insurance systems, targets, use of public vs private care, etc. 
Given this variance in implementation of residential (in-patient) treatment and the high 
associated costs, it is noteworthy that there has been little controlled examination of the 
outcomes and costs of residential treatment for anorexia nervosa relative to other approaches. 
The lack of adequate randomised controlled trials led NICE (2017) and Hay et al. (2019) to 
conclude that there is little evidence to support the hypothesised effectiveness of residential 
treatment settings for anorexia nervosa. A number of less controlled clinical studies have been 
presented, but they have substantial methodological variations (e.g., population, treatment, 
duration, outcomes measured), making it hard to draw firm conclusions about the 
effectiveness of such interventions. For example, Gowers et al. (2010) showed that there was 
substantial post-treatment weight loss and attrition following at least six weeks of residential 
treatment for adolescents with anorexia nervosa. In contrast, Brewerton and Costin (2011) 
found that a mean of 94 days of residential treatment for adults with anorexia nervosa was 
associated with positive longer term outcomes (body mass index [BMI] and eating attitudes), 
especially where the patient ended treatment with a higher discharge BMI. Fewell et al. (2017) 
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showed positive benefits in terms of BMI, eating attitudes and for a mixed group of adult and 
adolescent anorexia nervosa patients, with those benefits sustained into follow-up. However, 
their care involved a mix of residential care and partial hospitalisation, so the duration and 
impact of residential care per se cannot be determined. Furthermore, their outcomes were 
against a relatively high starting BMI (mean = 17.6). McHugh (2007) showed a positive BMI 
change and changes in restrictive attitudes among adolescents who undertook a mean of 28.5 
days of residential treatment for anorexia nervosa, but did not report follow-up outcomes. 
Finally, while Dalle Grave et al. (2013, 2014) have reported positive outcomes of a relatively 
long CBT-based residential programme for both adults and adolescents, the weight gain was 
not fully maintained into follow-up, particularly for adults. Given this mixture of outcomes, there 
are clearly some benefits, but they are inconsistent. It could be argued that residential 
treatment is not an effective way of helping patients to achieve full recovery, and might even 
result in negative outcomes, such as institutionalisation. 
Despite these limitations, it is clearly important to use residential treatment for some 
patients with anorexia nervosa, given the level of risk and the limited impact of evidence-based 
outpatient therapies (e.g., Bulik et al., 2007; National Institute for Health Care Excellence 
[NICE], 2017). Therefore, a strategic use of residential treatment is recommended within the 
NICE guidelines (NICE, 2017), where residential care (if necessary) can be used initially to 
ensure that the patient is safe, and then to begin addressing weight gain and psychological 
issues, but is not used to take the patient all the way to recovery. Such an approach means 
that any specialist residential anorexia nervosa treatment facility needs to be coordinated with 
local day- or outpatient facilities, to ensure that the patient transitions to the next stage of 
treatment effectively, in order that chances of long-term recovery are maximised. 
This stepped approach is relatively widely used in real-world settings. However, there 
is little evidence for its effectiveness. It is important to demonstrate that this approach can 
result in patients achieving adequate physical gains (especially BMI). However, it is equally 
necessary to demonstrate the psychological improvement (particularly improved eating 
attitudes) that is consequent on improved nutrition and reduced starvation effects (e.g., Waller 
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& Raykos, 2019), and which tends to be found relatively quickly and across therapies (e.g., 
Byrne et al., 2017; Waller et al., 2013). With that evidence in place, one can support the 
effectiveness of residential treatment being used to prepare patients for finalising weight and 
psychological gains in a less intensive setting. It is also important to consider whether this 
approach works differentially for adolescents and adults with anorexia nervosa, given that 
treatments, settings, legal powers and targets can differ substantially for these age groups 
(e.g., NICE, 2017). If outcomes and retention rates differ, then it might be necessary to modify 
this treatment approach for different age groups. In addition to age, it is important to determine 
whether other predictors of outcomes need to be taken into account. Pre-treatment pathology 
and early treatment response have each been considered as potential moderators and 
mediators of treatment outcome for eating disorders (e.g., Vall & Wade, 2015), but this area 
is less well explored in more intensive treatment settings. 
Therefore, the primary aim of this effectiveness study in a routine clinical setting was 
to determine whether residential treatment results in the intended clinical improvements (as 
opposed to aiming for full recovery), and whether that impact differs between adults and 
adolescents. Retention rate will also be compared across the two age groups. The secondary 
aim was to determine whether eating characteristics at the start of treatment were associated 
with greater or lesser improvement, and whether the level of early change in eating 
characteristics and weight/BMI predict outcomes of such an residential programme. 
Method 
Design and ethical considerations 
 The study used a case series design, considering change during residential treatment 
for adult and adolescent patients with anorexia nervosa. As this work reflects a service 
evaluation of existing practice, it did not require ethical clearance under UK National Health 
Service protocols. 
Participants 
All participants were female in-patients in a specialist eating disorders unit, undertaking 
a treatment for anorexia nervosa. Each was diagnosed by a specialist psychiatrist at entry to 
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the programme, using DSM-5 criteria (American Psychiatric Association, 2013). In the UK, 
such a programme is usually implemented when the patient has not been able to benefit from 
outpatient care in the first instance. In keeping with NICE (2017) guidance, this period of 
residential care is focused on ensuring that the patient progresses to being able to transition 
into outpatient care to complete their recovery. The core targets during this residential 
treatment are increased weight and attitudinal/behavioural change. However, the programme 
does not aim at effecting full recovery (e.g., stable and normal weight; quality of life; abstinence 
from behaviours; normalised body image), as this is the target of the subsequent outpatient 
treatment in local services.  
Ninety-eight patients started the treatment programme, and 83 completed it (see 
below). All met full DSM-5 criteria for anorexia nervosa. Thirty-five of the completers were 
adults (mean age = 27.2 years, SD = 11.0) and 48 were adolescents (mean age = 14.9 years, 
SD = 1.22). Intention-to-treat and completer analyses were both used. 
Measures and Procedure 
Two measures were used to determine outcome of this anorexia nervosa treatment. 
Body mass index (BMI) was calculated weekly, based on objectively measured height and 
weight. The Eating Disorders Examination Questionnaire (EDE-Q version 6; Fairburn, 2008) 
is a self-report measure, which was used to assess eating pathology at the beginning of 
treatment, at week 6, and at the end the treatment. The EDE-Q has strong psychometric 
properties (Berg, Peterson, Frazier & Crow, 2012), and includes scales addressing weight 
concerns, eating concerns, shape concerns, and restraint, as well as a composite Global 
scale. Finally, attrition was noted as an outcome if the patient opted to leave the therapy 
programme before the treatment reached the planned goals. 
Treatment 
 The treatment programmes for the adults and adolescents had common elements, 
though they diverged in terms of the psychological therapy used, the level of family 
involvement and the degree of occupational therapeutic input.  
All individuals were prescribed a weight gain diet, under medical and dietetic 
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supervision. The mean target weight gain was in the range of 0.5-1 kg/week. Adults and 
adolescents were assessed for individual therapies and, according to their clinical 
formulations, received a combination of cognitive behavioural therapy, body image therapy, 
and creative arts therapies. Adolescents routinely received family therapy, while adults were 
referred to family therapy when this was required. Parents and carers/family members of all 
patients were invited to attend a six-week course based on the Maudsley skills for carers 
approach (Hibbs et al., 2015) and a carers’ forum. Adolescents participated in a family meals 
and exposure programme, which involved meals being held first at the treatment setting and 
later at home (supported by team staff). In addition, a graded programme of snacks and meals 
out was implemented with both groups of patients (supported initially by team staff and then 
by carers). Support to eat at home was available to adults if required. 
Once at a healthier weight (75% of expected BMI for age), adolescents attended the 
in-house school. Later in treatment, they were supported with a gradual integration to their 
own school, which coincided with increasing amounts of overnight home leave. Adults 
received occupational therapy input, which focused on group therapeutic activities, healthy 
ways with food and mindfulness, as well as a range of activities to support engagement in 
work, social and leisure activities. Both adults and adolescents had access to therapeutic 
massage and a weekly movement meditation group. Patients’ care was planned and routinely 
reviewed at four- to six-weekly intervals, and progress against treatment goals was monitored 
through weekly team meetings.  
Completion of the programme was determined primarily by the clinical team judging 
that the individual patient had made enough progress to demonstrate that they would be able 
to use less intensive treatment. Usually, that required the patient to have gained a substantial 
amount of weight (reaching a BMI of c.17-18) and to have shown a substantial improvement 
in eating attitudes (towards or into the sub-clinical range, marked by a score of <2.77 on the 
EDE-Q Global score). In some cases, treatment extended slightly beyond that point, while 
transition to the next service was arranged. 
Data analysis 
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 Data were analysed separately for adolescents and adults, using completer and 
intention-to-treat (last number carried forwards) analyses. SPSS v.22 was used throughout. 
ANOVAs were used to determine any change in BMI and EDE-Q scores across the three time 
points, with post hoc Tukey tests used to determine pairwise differences. Effect sizes were 
measured using partial eta2 (large effect size = 0.14). Retention/attrition rates were compared 
across the two age groups using chi-squared tests. Pearson’s correlations were used to test 
the second aim, determining whether start of treatment characteristics or early change (over 
the first six weeks) predicted outcomes. 
Results 
Group characteristics 
Table 1 shows the ‘start of treatment’ characteristics of the adult and adolescent 
groups. The BMI and EDE-Q scores were in the range that one would normally expect to see 
for such groups. The adolescent group’s mean BMI for age was in the first centile. With the 
exception of age, there were no significant differences between the groups. It should be noted 
that the mean duration of treatment was relatively long compared to what would be on offer in 
many countries and under different insurance systems, though not as long as it would be in 
others.  
___________________________ 
Insert Table 1 about here 
___________________________ 
 
Clinical outcomes during residential phase of treatment 
 Table 2 shows changes in BMI and EDE-Q scores for the adults and the adolescents, 
using completer analyses to compare scores at the start of treatment, at week 6 of treatment, 
and at the end of treatment. In each group, BMI increased across the three time points, with 
the adults increasing their BMI by 2.9 points, and the adolescents moving from the 1st to the 
16th BMI centile for age. EDE-Q scores reduced substantially, with very large effect sizes. For 
both groups, the mean EDE-Q Global scores were within the normal range (< 2.77 = one SD 
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above the population mean) by the end of the residential phase of treatment. It is noteworthy 
that EQE-Q Shape concerns did not reduce until the latter part of therapy, suggesting that 
such cognitions improve after other cognitive elements of eating pathology. The only 
difference between the groups was that the EDE-Q Restraint score did not continue to 
decrease among adults, while it did for the adolescents.  
___________________________ 
Insert Table 2 about here 
___________________________ 
 
Considering the intention-to-treat analyses, Table 3 shows that the pattern of findings 
was broadly similar to those found in the completer analyses, with the expected lower level of 
effect (though all the effect sizes remained very large). Therefore, it can be concluded that this 
residential phase of treatment was effective in reducing the adults’ and adolescents’ eating 
pathology and increasing their BMI in line with the clinical aim - improvement so that the patient 
can transition to local services for continuation of their care in an outpatient setting. It is 
particularly noteworthy that the first six weeks of treatment resulted in a large proportion of 
that gain. 
___________________________ 
Insert Table 3 about here 
___________________________ 
 
Discharge routes for adult and adolescent patients 
Of the 94 patients for whom discharge route data were available, there was a tendency 
for adults to self-discharge more often than adolescents (16 out of 40 adult patients [40%] vs 
13 out of 54 adolescents [24.1%]). However, this association was not significant (X2 = 2.73, df 
= 1, two-tailed P = .098). 
Impact of pre-treatment eating characteristics on levels of symptom change 
To reduce the risk of Type 1 error, the remaining analyses will use the intention-to-
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treat approach only. Table 4 shows the correlations (Pearson’s r) between the patients’ EDE-
Q scores and BMI at the start of treatment and the level of change that they achieved across 
the course of their residential care, to determine whether there were any pre-treatment 
predictors of a poorer outcome. There was very little linkage between those early symptoms 
and change, among either adults or adolescents. The most consistent pattern was that lower-
BMI adult and adolescent patients gained more weight across the course of treatment. The 
only other association was among the adolescents, who were more likely to show 
improvement in their global eating pathology if they began with more negative body image. To 
summarise, the only effects found were that those patients with more negative initial eating 
pathology were likely to benefit more (rather than less). 
___________________________ 
Insert Table 4 about here 
___________________________ 
 
Impact of early change in eating on later levels of symptom change 
 Pearson’s r correlations were also used to determine whether there was any 
association of early change in EDE-Q scales and BMI (sessions 1 to 6) with subsequent 
change in overall EDE-Q Global score and BMI (session 6 to end of treatment). These 
analyses were carried out separately for adults and adolescents. There were no such 
associations among adolescents (P > .19 in all cases). The same was true among adults (P > 
.15 in all cases) with one exception – poor levels of early change in EDE-Q Shape concerns 
were associated with more positive later changes in overall EDE-Q scores (r = -.344; P < .03).  
Association of duration of treatment with levels of symptom change 
 Pearson’s r correlations were used to determine whether the duration of treatment was 
positively associated with the level of change across therapy. Among the adults, there was no 
association of treatment duration with change in EDE-Q Global scores (r = -.02; NS), but there 
was a positive association of duration with BMI change (r = .594; one-tailed P < .02). Among 
adolescents, there were no significant associations of treatment duration with changes in 
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EDE-Q Global scores and BMI (respectively - r = -.085 and r = .343, NS). These findings 
support the use of a longer residential stay among adults where the individual has poorer 
eating characteristics at the start of treatment. 
Discussion 
The primary aim of this effectiveness study was to ascertain whether residential 
treatment results in the intended partial clinical improvements among adults and adolescents, 
potentially facilitating subsequent treatment in less intensive settings. The second aim was to 
understand whether initial pathology plays a role in improvement and how early change in 
such factors relates to outcomes. There were the anticipated benefits of this treatment 
approach (a BMI increase of 2.5-3 points and a large BMI centile change for the adolescents; 
large reductions in EDE-Q scores). These findings are compatible with the existing literature 
on clinical outcomes during residential treatment, as outlined in the Introduction. The initial 
period of treatment was associated with particularly substantial levels of progress. However, 
that early change was not associated with later levels of benefit. Similarly, initial pathology 
played a very limited role in predicting outcome, with the most consistent finding being that 
starting treatment at a lower BMI was associated with a greater increase in BMI by the end of 
treatment (as also found by Raykos et al., 2018).  
This finding supports the use of residential treatment programmes for the early part of 
treatment of relatively severe, high-risk anorexia nervosa, whether for adults or adolescents. 
While the process of symptom interruption and the achievement of weight gain might explain 
a large part of any wider improvement, it is also possible that the nature of the programme 
matters too. Therefore, any such programme needs to demonstrate evidence of its 
effectiveness. The findings differ from those of the wider treatment literature for eating 
disorders (Vall & Wade, 2015) in one substantive way – early change did not result in greater 
later change. Otherwise, these findings are compatible with the wider literature, with the lack 
of pre-treatment predictors of weight gain and the larger levels of change in the early part of 
treatment being similar to the findings of other research (e.g., Raykos et al., 2013; Turner et 
al., 2015; Vall & Wade, 2015).  
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Obviously, these findings do not guarantee that such patients will reach full recovery, 
as that is dependent on multiple factors that are beyond the control of the residential unit itself 
(e.g., the patients’ engagement with the relevant subsequent treatment; the availability of such 
treatment; the quality of such care). Transitional arrangements are clearly likely to be 
important in enhancing the potential for full recovery, determining continuity of care and the 
development of new goals (e.g., final weight gain; relapse prevention). They are also likely to 
differ between younger and older patients, as a return to full-time education or a move to 
College or University are more likely with the younger group. 8 However, this intensive initial 
approach has demonstrated gains in lines with goals of the NICE-recommended (2017) 
approach to the limited use of residential treatment. 
The patients in this case series were treated using a single protocol for each age group 
(albeit adapted to individual needs). It is possible that such gains could be made with different 
treatment components (e.g., different psychological therapies) or with other forms of intensive 
intervention (e.g., day-patient care), though weight gain would need to remain the primary 
clinical outcome for adults and for adolescents (Bulik et al., 2007). Any such approach would 
meet the NICE recommendation (NICE, 2017) of initiating intensive treatment for anorexia 
nervosa only if it is necessary, and maintaining it only while it results in substantial change.  
This study has a number of limitations. For example, while information about previous 
successful or unsuccessful treatment experiences was not available in this study, it would be 
important to consider those experiences in future studies, to determine which patients might 
benefit more from such intensive work. Similarly, it would have been useful if this study had 
systematically assessed comorbidity (e.g., anxiety, depression, personality pathology, trauma 
reactions) at assessment, in order to characterize the sample more clearly. Such information 
should be gathered routinely in future studies. A further issue is the cultural specificity of such 
findings, where the availability and length of intensive treatments varies widely. For example, 
in many countries, this long a period of residential treatment would not have been available to 
all or any patients, due to limited insurance and bed provision. However, it is positive to note 
that a very substantial amount of benefit was established in just six weeks, making it possible 
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to use residential provision to get substantial clinical gains even in a much shorter time. 
Obviously, the degree to which these smaller early changes prepare patients for subsequent 
treatment needs to be considered in research conducted in other cultures. However, the 
greater benefits of longer therapy for patients who start as a lower BMI do support the need 
to ensure that such patients are offered longer periods of intensive treatment. Finally, the 
attrition rate might have been influenced by a combination of factors, including the planned 
goals and the fact that the treatment funding was largely based on public insurance costs, 
meaning that patients could drop out of treatment without the fear of losing the access to 
funded treatment in future. Therefore, the attrition rate for different cultures needs to be 
explored in future work. 
A key issue raised by this study is that the most substantial period of symptom change 
is in the first six sessions of treatment. This raises the clinical question of whether residential 
treatment should be extended beyond this period of rapid change, or whether the transition to 
less intensive care should take place much earlier than it did in this clinical sample. Different 
clinical cultures set this time period as longer than in this study (aiming for complete recovery 
or full weight regain while in residential care), while others have shorter residential periods 
(more in keeping with this six-week period. At present, there is no evidence to support setting 
a particular time frame, though the goal of shorter residential care is clearly one that has 
patient benefit at its heart, as well as minimizing financial costs (e.g., NICE, 2017). Over-
extended periods in residential care risk the patient lacking intrapersonal coping skills for 
functioning in other settings, making relapse risk higher. However, excessively short periods 
carry the risk of the patient lacking many of the skills that they could be learning, with the same 
heightened risk of relapse. The optimum point for stepping down care is also likely to depend 
on patient characteristics. Therefore, it is important that future research should address the 
issue of what temporal, treatment and patient characteristics predict the optimum outcome 
from residential care, so that stepping down levels of care can be made as clinically effective 
as possible. However, the early change found in this study indicates that clinicians and 
researchers would be best advised to start with the assumption that any additional residential 
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stay beyond a relatively short period would need to be justified rather than assumed to be 
clinically useful. Such an assumption of brevity as the norm is in keeping with NICE’s (2017) 
recommendations.  
Further research is needed to address the questions raised here – are the same results 
found among patients who receive other intervention patterns, and are they maintained into 
progress through to later in treatment, resulting in recovery? Multiple therapeutic and service 
factors will need to be considered in order to determine what makes for an effective initial 
approach, what makes for an effective transitional arrangement, and what constitutes the 
optimum subsequent therapy, leading to recovery. It has been indicated in the Introduction 
that this literature lacks a consistent approach to clinical research, weakening the case for 
residential treatment, particularly in the absence of adequately controlled or followed-up 
studies (e.g., Hay et al., 2019; NICE, 2017). Such controlled trials are urgently needed, and 
there should be consideration of what constitutes the optimum duration of such intensive and 
costly interventions. It is also important to consider that the optimum final part of therapy might 
differ according to the nature of the more intensive first part. Finally, differences in gender, 
ethnicity and socio-economic background might be relevant, and should be considered in this 
field of treatment research. 
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Table 1 
Group characteristics at the start of treatment 
 
 Adults Adolescents  t-test 
M (SD) M (SD) t P 
Age (years) 27.2 (11.0) 14.9 (1.22) 8.94 .001 
Length of admission (days) 139.3 (70.1) 119.7 (62.1) 1.49 .140 
Body Mass Index 14.7 (1.82) 15.0 (1.74) 1.08 .281 
EDEQ Global  4.37 (1.31) 4.07 (1.49) 1.03 .305 
EDEQ Restraint 4.33 (1.71) 3.76 (1.69) 1.64 .104 
EDEQ Eating Concerns 3.84 (1.41) 3.51 (1.40) 1.14 .258 
EDEQ Weight Concerns 4.44 (1.50) 4.04 (1.68) 1.23 .223 
EDEQ Shape Concerns 4.88 (1.31) 4.97 (2.51) 0.22 .825 
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Table 2  
 
Improvements in eating pathology over course of residential treatment (completer analysis) 
 
  Start of 
treatment (SoT) 





Group Measure M (SD) M (SD) M (SD) F P Partial 
eta2 
Post hoc tests  
(P < .05) 
Adolescents BMI 15.0 (1.61) 16.7 (1.54) 18.1 (1.66) 57.8 .001 .738 SoT < Wk6 < EoT 
EDEQ Global 
 
3.74 (1.46) 2.76 (1.52) 1.55 (1.56) 26.3 .001 .556 SoT > Wk6 > EoT 
EDEQ Restraint 
 
3.36 (1.89) 1.45 (1.55) 0.96 (1.44) 27.7 .001 .569 SoT > Wk6 > EoT 
EDEQ Eating 
Concerns 
3.36 (1.33) 2.43 (1.57) 1.16 (1.29) 25.1 .001 .556 SoT > Wk6 > EoT 
EDEQ Weight 
Concerns 
3.71 (1.77) 3.16 (1.84) 1.57 (1.69) 16.1 .001 .447 SoT > Wk6 > EoT 
EDEQ Shape 
Concerns 
4.38 (1.47) 3.91 (1.65) 2.23 (2.00) 16.8 .001 .444 SoT = Wk6 > EoT 
Adults BMI 14.6 (1.83) 16.1 (1.75) 17.5 (1.76) 41.2 .001 .548 SoT < Wk6 < EoT 
EDEQ Global 
 
4.16 (1.38) 3.45 (1.47) 2.29 (1.62) 27.0 .001 .574 SoT > Wk6 > EoT 
EDEQ Restraint 
 
3.96 (1.79) 2.17 (1.61) 1.76 (1.54) 20.0 .001 .526 SoT > Wk6 = EoT 
EDEQ Eating 
Concerns 
3.55 (1.39) 2.92 (1.38) 1.93 (1.57) 21.7 .001 .520 SoT > Wk6 > EoT 
EDEQ Weight 
Concerns 
4.40 (1.32) 3.89 (1.72) 2.42 (1.97) 19.8 .001 .497 SoT = Wk6 > EoT 
EDEQ Shape 
Concerns 
4.68 (1.49) 4.74 (1.68) 3.11 (1.89) 15.0 .001 .429 SoT = Wk6 > EoT 
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Table 3  
 
Improvements in eating pathology over course of residential treatment (intention-to-treat analysis) 
 
  Start of 
treatment (SoT) 





Group Measure M (SD) M (SD) M (SD) F P Partial 
eta2 
Post hoc tests  
(P < .05) 
Adolescents 
 
(N = 54) 
BMI 15.1 (1.74) 16.6 (1.70) 17.5 (1.94) 54.0 .001 .639 SoT < Wk6 < EoT 
EDEQ Global 
 
4.01 (1.40) 3.16 (1.72) 2.51 (1.95) 20.0 .001 .445 SoT > Wk6 > EoT 
EDEQ Restraint 
 
3.76 (1.69) 2.30 (1.93) 1.94 (1.99) 21.9 .001 .467 SoT > Wk6 > EoT 
EDEQ Eating 
Concerns 
3.51 (1.40) 2.73 (1.67) 2.07 (1.81) 20.9 .001 .465 SoT > Wk6 > EoT 
EDEQ Weight 
Concerns 
4.04 (1.68) 3.54 (2.02) 2.75 (2.23) 11.4 .001 .313 SoT > Wk6 > EoT 
EDEQ Shape 
Concerns 
4.72 (1.57) 4.11 (1.85) 3.28 (2.22) 12.0 .001 .325 SoT = Wk6 > EoT 
Adults 
 
(N = 44) 
BMI 14.7 (1.82) 15.9 (1.68) 16.9 (1.90) 40.6 .001 .623 SoT < Wk6 < EoT 
EDEQ Global 
 
4.37 (1.31) 3.78 (1.46) 3.02 (1.85) 25.1 .001 .539 SoT > Wk6 > EoT 
EDEQ Restraint 
 
4.33 (1.71) 3.01 (1.98) 2.50 (1.96) 26.9 .001 .562 SoT > Wk6 > EoT 
EDEQ Eating 
Concerns 
3.84 (1.41) 3.23 (1.42) 2.46 (1.68) 26.4 .001 .551 SoT > Wk6 > EoT 
EDEQ Weight 
Concerns 
4.43 (1.50) 4.07 (1.71) 3.19 (2.13) 15.1 .001 .412 SoT = Wk6 > EoT 
EDEQ Shape 
Concerns 
4.88 (1.31) 4.84 (1.47) 3.86 (1.97) 12.4 .001 .367 SoT = Wk6 > EoT 
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Table 4 
Association of early eating characteristics with level of change in eating pathology from 
baseline to discharge 











BMI -.545** .090 -.441** -.004 
EDE-Q Global -.110 -.044 -.007 .222 
EDE-Q Restraint -.095 .040 .066 .222 
EDEQ Eating concerns -.006 -.096 -.167 .158 
EDE-Q Weight concerns -.202 -.010 -.060 .132 
EDE-Q Shape concerns -.126 -.096 -.051 .277 
    
* P < .05; ** P < .001 
 
